28 research outputs found
Additional file 1 of Temporal topic model for clinical pathway mining from electronic medical records
Additional file 1
Primers for Bacteroidetes, Firmicutes, and total bacteria.
<p>Primers for Bacteroidetes, Firmicutes, and total bacteria.</p
Effects of RC and berberine on gene expressions in visceral adipose tissues and livers.
<p>āNormalā, normal chow diet-fed mice; āHFDā, high-fat diet-fed control mice; āberberineā, berberine-treated HFD mice; āRCā, <i>Rhizoma coptidis</i>-treated HFD mice. Data were expressed as MeanĀ±S.D. (nā=ā6), *<i>P</i><0.05, **<i>P</i><0.01 vs. HFD controls.</p
Effects of RC and berberine on growth of fecal bacteria ex vivo under (a) aerobic and (b) anaerobic conditions.
<p>āNormalā, normal chow diet-fed mice; āHFDā, high-fat diet-fed control mice; āBerberineā, Berberine-treated HFD mice; āRCā, Rhizoma Coptidis-treated HFD mice (nā=ā6).</p
Effects of RC and berberine on Fiaf protein expressions in intestinal and adipocyte tissues.
<p>āNormalā, normal chow diet-fed mice; āHFDā, high-fat diet-fed control mice; āberberineā, berberine-treated HFD mice; āRCā, <i>Rhizoma coptidis</i>-treated HFD mice. Data were expressed as MeanĀ±S.D. (nā=ā6), *<i>P</i><0.05, **<i>P</i><0.01 vs. HFD controls.</p
Effects of (a) berberine and (b) RC on the growth of <i>Lactobacillus</i> sp. under anaerobic conditions in vitro.
<p>Effects of (a) berberine and (b) RC on the growth of <i>Lactobacillus</i> sp. under anaerobic conditions in vitro.</p
Effects of RC and berberine on (a) body weight and (b) visceral adipose tissue weight in HFD mice.
<p>āNormalā, normal chow diet-fed mice; āHFDā, high-fat diet-fed control mice; āberberineā, berberine-treated HFD mice; āRCā, <i>Rhizoma coptidis</i>-treated HFD mice. Data were expressed as MeanĀ±S.D. (nā=ā10), *<i>P</i><0.05, **<i>P</i><0.01 vs. HFD controls.</p
Effects of RC and berberine on blood biochemical assay parameters, metabolic cage trials, and fecal lipid and polysaccharide evaluations in HFD mice.
<p>āNormalā, normal chow diet-fed mice; āHFDā, high-fat diet-fed control mice; āberberineā, berberine-treated HFD mice; āRCā, <i>Rhizoma coptidis</i>-treated HFD mice. Data were expressed as MeanĀ±S.D. (nā=ā10),</p><p>*<i>P</i><0.05,</p><p>**<i>P</i><0.01 vs. HFD controls.</p
HPLC fingerprint of ethanol extracts of <i>Rhizoma coptidis</i> (RC).
<p>Chromatogram conditions: Kromasil C18 column (5 Āµm, 4.6 mmĆ250 mm), column temperature, 30Ā°C; mobile phase, acetonitrile: H<sub>2</sub>O (0.05 M KH2PO4, pH 3.0)ā=ā30ā¶70 (v/v); elution rate, 1 ml/min; detector wavelength, 345 nm. Peak ā1ā, berberine (content, 24.2%).</p